"10.1371_journal.pgen.1004235","plos genetics","2014-04-03T00:00:00Z","Inga Prokopenko; Wenny Poon; Reedik Mägi; Rashmi Prasad B; S Albert Salehi; Peter Almgren; Peter Osmark; Nabila Bouatia-Naji; Nils Wierup; Tove Fall; Alena Stančáková; Adam Barker; Vasiliki Lagou; Clive Osmond; Weijia Xie; Jari Lahti; Anne U Jackson; Yu-Ching Cheng; Jie Liu; Jeffrey R O'Connell; Paul A Blomstedt; Joao Fadista; Sami Alkayyali; Tasnim Dayeh; Emma Ahlqvist; Jalal Taneera; Cecile Lecoeur; Ashish Kumar; Ola Hansson; Karin Hansson; Benjamin F Voight; Hyun Min Kang; Claire Levy-Marchal; Vincent Vatin; Aarno Palotie; Ann-Christine Syvänen; Andrea Mari; Michael N Weedon; Ruth J F Loos; Ken K Ong; Peter Nilsson; Bo Isomaa; Tiinamaija Tuomi; Nicholas J Wareham; Michael Stumvoll; Elisabeth Widen; Timo A Lakka; Claudia Langenberg; Anke Tönjes; Rainer Rauramaa; Johanna Kuusisto; Timothy M Frayling; Philippe Froguel; Mark Walker; Johan G Eriksson; Charlotte Ling; Peter Kovacs; Erik Ingelsson; Mark I McCarthy; Alan R Shuldiner; Kristi D Silver; Markku Laakso; Leif Groop; Valeriya Lyssenko","Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London, United Kingdom; Department of Clinical Science, Diabetes & Endocrinology, Lund University Diabetes Centre, Malmö, Sweden; Estonian Genome Center, University of Tartu, Tartu, Estonia; University of Lille Nord de France, Lille, France; CNRS UMR8199, Institut Pasteur de Lille, Lille, France; INSERM U970, Paris Cardiovascular Research Center PARCC, Paris, France; Department of Clinical Science, Neuroendocrine Cell Biology, Lund University Diabetes Centre, Malmö, Sweden; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom; Peninsula College of Medicine and Dentistry, University of Exeter, Exeter, United Kingdom; Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland; Folkhälsan Research Centre, Helsinki, Finland; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, United States of America; Division of Endocrinology Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; Department of Mathematics, Åbo Akademi University, Turku, Finland; Epigenetics and Diabetes Unit, Department of Clinical Sciences, Lund University, CRC, Scania University Hospital, Malmö, Sweden; Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland; Department of Pharmacology and Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; INSERM - Institut de Santé Publique, Paris, France; INSERM CIC EC 05, Hôpital Robert Debré, Paris, France; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland; Program in Medical and Population Genetics and Genetics Analysis Platform, The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusettes, United States of America; Molecular Medicine, Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; CNR Institute of Biomedical Engineering, Padova, Italy; Department of Clinical Science, Internal Medicine, Skåne University Hospital Malmö, Malmö, Sweden; Department of Social Service and Health Care, Jakobstad, Finland; University of Leipzig, Department of Medicine, Leipzig, Germany; University of Leipzig, IFB Adiposity Diseases, Leipzig, Germany; Institute of Biomedicine/Physiology, University of Eastern Finland, Kuopio, Finland; Kuopio Research Institute of Exercise Medicine, Kuopio, Finland; Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; Helsinki University, Department of General Practice and Primary Health Care, Helsinki, Finland; Helsinki University Central Hospital, Unit of General Practice, Helsinki, Finland; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kindom; Baltimore Geriatric Research, Education and Clinical Center, Baltimore, Maryland, United States of America; Steno Diabetes Center A/S, Gentofte, Denmark","Conceived and designed the experiments: IP WP RM RPB SAS PO NW TD CLi KDS ML LG VLy. Performed the experiments: WP RM RPB SAS PO NW TD KH. Analyzed the data: IP WP RM RPB SAS PA PO NBN NW TF AS AB VLa CO WX JLa AUJ YCC JLi JRO PAB JF SA TD EA JT CLe AK OH KH BFV HMK CLM VV MNW RJL KKO CLa AT RR JK CLi PK KDS VLy. Contributed reagents/materials/analysis tools: SAS PA PO NW AP ACS AM PN BI TT NJW MS EW TAL TMF PF MW JGE CLi EI ARS KDS ML LG VLy. Wrote the paper: IP WP RM RPB PO NW AB MIM CLi LG VLy.","I have read the journals policy and we have the following conflicts: VLy declares that Steno Diabetes Center is owned by Novonordisk, PK is funded by Boehringer Ingelheim Foundation, TF received payment for lectures from MSD (Merck), AM is a consultant for Eli Lilly and Poxel and has received grants from Eli Lilly and Boehringer Ingelheim, BI has received payment for lectures from Boehringer Ingelheim, MSD, Novo Nordisk Farma and AstraZeneca, LG has been a consultant for and served on advisory boards for Sanofi-Aventis, GSK, Novartis, Merck, Tethys Bioscience and Xoma, and received lecture fees from Lilly and Novartis. We confirm that these affiliations do not alter the adherence to all the PLOS Genetics policies on sharing data and materials.","2014","04","Inga Prokopenko","IP",64,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
